Skip to content

Clinical trials

Achondroplasia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Achondroplasia Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20192
20201
20211
20233
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Enrolling by invitation2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company5
Ascendis Pharma A/S3
Ascendis Pharma Growth Disorders A/S2
BioMarin Pharmaceutical1
Pfizer1
Tyra Biosciences, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Achondroplasia13
Bone Diseases6
Dwarfism6
Musculoskeletal Diseases6
Osteochondrodysplasias6
Genetic Diseases, Inborn5
Mucopolysaccharidosis IV5
Bone Diseases, Developmental1
Growth Disorders1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.